Full Text View
Tabular View
No Study Results Posted
Related Studies
Open-Label Adjunctive Zonisamide for Bipolar Disorder
This study has been terminated.
Study NCT00047567   Information provided by Elan Pharmaceuticals
First Received: October 8, 2002   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Disorders
Additional conditions recognized in this trial
Bipolar Disorder
Disease
More general conditions related to this trial
Affective Disorders, Psychotic
Mental Disorders
Mood Disorders
Pathologic Processes
Interventions listed in this trial
zonisamide
More general drug interventions related to this trial
Anticonvulsants
Antioxidants
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Elan Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services